Crinetics Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Crinetics Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Crinetics Pharmaceuticals Inc
Rating: 1.47016675
Author: Trendlyne DVM scores

about

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and...

42.70 -1.38 (-3.13%)

26.37% Fall from 52W High

1.4M

XNAS Volume

XNAS 13 Feb, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Crinetics Pharma Inc is on 27 Feb 2026 for the purpose of Crinetics Pharmaceuticals Inc Fourth Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

6.7 / 100

Technically Neutral

52.1 / 100

1Yr Price target upside is 99%

14 analysts

Crinetics Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Crinetics Pharma Inc Live Stock Price Today, Share Analysis and Chart

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and...

26.37% Fall from 52W High

SWOT Analysis

Crinetics Pharma Inc Live Price Chart